Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 482
Immune Disorders Drugs 201
Drug Discovery 169
Cardiovascular Drugs 159
Infectious Diseases Drugs 138
Biopharmaceuticals 133
Clinical Trials 126
Endocrine and Metabolic Disorders Drugs 110
Central Nervous System Drugs 100
Pharmaceuticals 95
Musculoskeletal Disorders Drugs 94
Leukemia Drugs 84
Hematological Drugs 83
Liver and Kidney Disorders Drugs 81
Lymphoma Drugs 62
Dermatological Drugs 55
Diabetes Drugs 54
Skin Cancer Drugs 51
Brain Cancer Drugs 45
Respiratory Drugs 44
Gastrointestinal Drugs 41
Mental Disorders Drugs 41
Lung Cancer Drugs 39
Pharmaceutical Intermediates 38
Drug Delivery 37
Immunosuppressive Drugs 34
Pharmaceutical Manufacturing 33
Infusions and Injectables 30
Liver Cancer Drugs 28
Bladder Cancer Drugs 25
Analgesics 25
Drugs by Therapeutic Area 24
Antibiotics 23
Kidney Cancer Drugs 22
Colon Cancer Drugs 20
HIV/AIDS Drugs 20
Prostate Cancer Drugs 18
Pancreatic Cancer Drugs 18
Schizophrenia Drugs 18
Urological Disorders Drugs 17
Sexual and Reproductive Health Drugs 15
Ovarian Cancer Drugs 14
Cervical Cancer Drugs 14
Breast Cancer Drugs 13
Cancer Vaccines 13
Thyroid Cancer Drugs 12
Psoriasis Drugs 12
Generic Drugs 10
Biosimilars and Biosuperiors 10
Over the Counter (OTC) Drugs 9
Vaccines 9
Transdermal and Transmucosal Drug Delivery 8
Anti-Obesity Drugs 8
Optical Disorders Drugs 7
Alzheimer's Disease Drugs 7
Uterine Cancer Drugs 6
Company Reports 5
Anxiety Drugs 4
Pharmacoeconomics 3
Cough and Cold Drugs 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



276 reviews

2,463 Results (Page 19 of 124)
- Relevance
  Sort by

Basal Cell Carcinoma (Basal Cell Epithelioma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
August 2022
245 Pages
Global

From

€1987EUR$2,000USD£1,652GBP

Glioblastoma Multiforme Treatment Market Report and Forecast 2024-2032

 Report
September 2023
200 Pages
Global

From

€2979EUR$2,999USD£2,477GBP

Schizophrenia Drugs Market Report and Forecast 2023-2031

 Report
April 2023
147 Pages
Global

From

€5960EUR$5,999USD£4,955GBP

Recurrent Glioblastoma Multiforme (GBM) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

 Report
May 2022
548 Pages
Global

From

€2484EUR$2,500USD£2,065GBP

Glioblastoma Multiforme (GBM) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

 Report
May 2022
1381 Pages
Global

From

€2484EUR$2,500USD£2,065GBP

NEED HELP FINDING THE RIGHT PRODUCT? Craig will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Non-Melanoma Skin Cancer Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

 Report
December 2023
201 Pages
Global

€4962EUR$4,995USD£4,126GBP

Bispecific Antibodies Market (5th Edition): Distribution by Therapeutic Area, Mechanism of Action, Target Antigen, Antibody Format, Key Players and Key Geographical Regions (North America, Europe, Asia and Rest of the World): Industry Trends and Global Forecasts, 2023-2035

 Report
May 2023
391 Pages
Global

From

€4768EUR$4,799USD£3,964GBP

Global Peptide Therapeutics Market, Drug Dosage, Price & Clinical Trials Insight 2029

 Report
November 2023
1800 Pages
Global

From

€5067EUR$5,100USD£4,213GBP

Duchenne Muscular Dystrophy Drugs - Global Strategic Business Report

 Report
November 2024
220 Pages
Global

From

€4918EUR$4,950USD£4,089GBP

Type 2 Diabetes Drugs Market by Drug, Application, Distribution - Global Forecast 2025-2030

 Report
October 2024
181 Pages
Global

From

€3522EUR$3,545USD£2,928GBP

€3913EUR$3,939USD£3,254GBP

Diabetes Drugs Market by Product, Application, Distribution Channel - Global Forecast 2025-2030

 Report
October 2024
197 Pages
Global

From

€3522EUR$3,545USD£2,928GBP

€3913EUR$3,939USD£3,254GBP

Global Cell Therapy Biomanufacturing Market 2024-2029

 Report
August 2024
112 Pages
Global

From

€4620EUR$4,650USD£3,841GBP

Liver Fibrosis Drugs Market by Drug Type, Distribution Channel - Global Forecast 2025-2030

 Report
October 2024
199 Pages
Global

From

€3522EUR$3,545USD£2,928GBP

€3913EUR$3,939USD£3,254GBP

Liver Diseases Therapeutics Market by Treatment, End User - Global Forecast 2025-2030

 Report
October 2024
181 Pages
Global

From

€3522EUR$3,545USD£2,928GBP

€3913EUR$3,939USD£3,254GBP

End Stage Renal Disease Market by Treatment, Diagnosis, End-User - Global Forecast 2025-2030

 Report
October 2024
197 Pages
Global

From

€3522EUR$3,545USD£2,928GBP

€3913EUR$3,939USD£3,254GBP

Asia-Pacific Bladder Cancer Therapeutics and Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

 Report
January 2022
78 Pages
Asia Pacific

From

€4719EUR$4,750USD£3,923GBP

Uveal Melanoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
June 2022
207 Pages
Global

From

€1987EUR$2,000USD£1,652GBP

Systemic Lupus Erythematosus (Sle) Drugs - Global Strategic Business Report

 Report
November 2024
184 Pages
Global

From

€4918EUR$4,950USD£4,089GBP

Hydroxyurea Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2023
74 Pages
Global

From

€3500EUR$3,774USD£3,012GBP

Rheumatoid Arthritis Therapeutics - Global Strategic Business Report

 Report
November 2024
150 Pages
Global

From

€5563EUR$5,600USD£4,626GBP

2,463 Results (Page 19 of 124)
- 1
- 17
- 18
- 19
- 20
- 21

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.